Articles tagged "Liver transplantation"

2019 American Transplant Congress
Karnofsky Performance Score as a Predictor of Acute Cellular Rejection Post Liver Transplantation
N. Kapila¹, K. Al Khalloufi², F. Salomon³, K. Kapila⁴, A. Gupta³, X. B. Zervos²
¹Gastroenterology and Hepatology, Cleveland Clinic Florida, Weston, FL, ²Transplant, Cleveland Clinic Florida, Weston, FL, ³Internal Medicine, Cleveland Clinic Florida, Weston, FL, ⁴Internal Medicine, University of Miami/JFK Medical Center, Atlantis, FL
*Purpose: The incidence of acute cellular rejection (ACR) following liver transplantation (LT) ranges from 20-40%. Development of ACR is associated with increased risk of graft…
2019 American Transplant Congress
Comprehensive and Combined Transcriptomic and Proteomic Analysis Reveals Key Factors Underlying Ischemia-Reperfusion Injury in Human Liver Transplantation
S. Huang, X. He, C. Sun, Z. Guo, W. Ju, Z. Zhu, Q. Zhao, G. Chen
Organ Transplant Center, the First Affiliated Hospital of SYSU, Guangzhou, China
*Purpose: Ischemia-reperfusion injury (IRI) is a major challenge in liver resection and liver transplantation surgery. Hepatic IRI can seriously impair liver function and even cause…
2019 American Transplant Congress
Clinical Features and Prognosis of Diffuse Intrahepatic Biliary Stricture in Adult ABO-Incompatible Living Donor Liver Transplantation
J. Kwon, G. Song, S. Hwang, K. Kim, C. Ahn, D. Moon, T. Ha, D. Jung, G. Park, Y. Yoon, H. Cho, I. Jeong, J. Choi, S. Yoo, S. Lee
Division of Liver Transplantation and Hepatobiliary Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
*Purpose: Despite the advancement in desensitization protocol, diffuse intrahepatic biliary stricture (DIHBS), an attenuated form of antibody mediated rejection (AMR), remains an unresolved problem. As…
2019 American Transplant Congress
Results of Litmus (nct 02541916): The Liver Immune Tolerance Bio Marker Utilization Study
A. Chruscinski¹, V. Rojas-Luengas¹, S. Moshkelgosha¹, J. Luo², H. Yowanto², Z. Galvin¹, L. Lilly¹, R. Smith¹, E. Renner¹, J. Zhang¹, D. Grant¹, O. Adeyi¹, H. Atkins³, P. Juni⁴, N. Selzner¹, S. Juvet¹, G. Levy¹
¹Multi-Organ Transplantation, University Health Network, Toronto, ON, Canada, ²Sciex, Brea, CA, ³Ottawa Hospital Research Institute, Ottawa, ON, Canada, ⁴University of Toronto, Toronto, ON, Canada
*Purpose: Previously we reported a novel biomarker gene set for the identification of tolerance in murine models of rapamycin-induced cardiac tolerance and spontaneous hepatic tolerance.…
2019 American Transplant Congress
Alcohol Recidivism In Liver Transplant Recipients With Alcoholic Liver Disease: Does Six-months Abstinence Rule Still Holds True?
S. K. Satapathy¹, C. Thornburgh¹, J. Yu², J. Eason¹, S. Kedia², D. Maluf¹
¹UTHSC, Memphis, TN, ²University of Memphis, Memphis, TN
*Purpose: Liver transplant for alcoholic liver disease (ALD) continues to be a challenge for transplant centers, particularly related to the ethical dilemma of transplanting or…
2019 American Transplant Congress
Global and Domain Specific Cognition in Liver Transplant Recipients
D. Ko¹, L. Bratzke²
¹School of Nursing, Vanderbilt University, Nashville, TN, ²School of Nursing, University of Wisconsin-Madison, Madison, WI
*Purpose: Liver transplant (LT) recipients may experience global or domain-specific cognitive impairment (CI) (e.g., attention and memory) post-transplant due to multiple potential factors such as…
2019 American Transplant Congress
Hephaistos Study Outcome on Renal Function after 12 Month Everolimus Plus Reduced Tacrolimus in De Novo Liver Transplant Recipients versus Standard Tacrolimus
F. Braun¹, P. Schemmer¹, H. Schlitt¹, A. Pascher¹, C. Klein¹, U. Neumann¹, I. Kroeger², P. Wimmer², B. Nashan¹
¹Study Group, Hephaistos, Germany, ²Novartis Pharma GmbH, Nuernberg, Germany
*Purpose: The HEPHAISTOS study was designed to compare efficacy and safety of earlyuse of everolimus [EVR] combined with reduced tacrolimus [rTAC] versus Standard tacrolimus [TAC-C)…
2019 American Transplant Congress
Post-Reperfusion Hepatic Beta-Catenin Activation Regulates Graft Damage, Inflammatory Responses and Transplant Outcomes
H. Hirao, K. Kadono, S. Kageyama, K. Nakamura, T. Ito, J. Aziz, K. J. Dery, F. M. Kaldas, R. W. Busuttil, J. W. Kupiec‐Weglinski
Dumont-UCLA Transplant Center, UCLA, Los Angeles, CA
*Purpose: Hepatic ischemia-reperfusion injury (IRI), an innate-immune driven hepatic inflammation response, represents a major risk factor of early allograft dysfunction (EAD) and rejection in liver…
2019 American Transplant Congress
Does Secondary Simultaneous Liver Kidney versus Liver Alone Make a Difference in Terms of Patient and Graft Survival
C. Blanton, J. Reyes, M. Eerhart, P. Chlebeck, L. Fernandez
University of Wisconsin, Madison, WI
*Purpose: Survival benefits have been shown with primary simultaneous liver kidney (SLK) transplantation as well as kidney after primary liver transplant when patients develop kidney…
2019 American Transplant Congress
Syphilis Transmission in Solid Organ Transplantation
M. Morrison, M. Hurtik, G. M. Lyon, S. Pouch
Emory University Hospital, Atlanta, GA
*Purpose: Syphilis is a sexually transmitted infection that affects people worldwide. While transmission generally occurs via sexual contact, other modes of transmission are possible, including…